ISPE’s Women in Pharma® group advocates for accelerated equality in the pharmaceutical industry and beyond. Through virtual and in-person programming, Women in Pharma provides ISPE members the resources necessary to challenge the status quo and make an impact on both a personal and professional level.
This summer has been, and will continue to be, quite busy with...
Paperless validation – Oxymoron, perhaps? Is there really a truly paperless validation solution out there, one that fits the needs of the validation lifecycle? The ISPE Sub-Committee for Paperless Validation has defined ‘Paperless Validation Systems’ as Paperless solutions enable validation lifecycle deliverables to be generated, approved, and more importantly, testing to be completed without...
ISPE’s Women in Pharma® Hosts a Self Defense and Kickboxing Class at the 2023 ISPE Annual Meeting & Expo.
When discussing manufacturing execution concepts and practices, it is useful to first take a top-down look at life sciences needs and the regulatory/guidance environment.
Pharmaceutical and biopharmaceutical professionals at all levels of the industry gathered in Amsterdam, The Netherlands for the 2023 ISPE Europe Annual Conference to share progress, success stories, best practices, and lessons learned. This year was a major success with a wide range of topics addressing advancements in technology and policy initiatives that are transforming the pharmaceutical...
Novel cell and gene therapies are already revolutionizing medicine. These new therapies can modify a patient's DNA and transform their cells into powerful tools for treating a wide range of diseases, from cystic fibrosis and heart disease to diabetes, hemophilia, and cancer. The introduction of groundbreaking technologies such as CRISPR gene editing has already produced significant...
